BRIEF published on 10/21/2025 at 18:35, 5 months 1 day ago Theraclion obtains crucial certification in China Medical Theraclion SONOVEIN® Focused Ultrasound Chinese Certification
BRIEF published on 10/21/2025 at 18:35, 5 months 1 day ago Theraclion obtient une certification cruciale en Chine Medical Theraclion SONOVEIN® Ultrasons Focalisés Certification Chinoise
PRESS RELEASE published on 10/21/2025 at 18:30, 5 months 1 day ago Informations privilégiées / Autres communiqués Theraclion obtient une certification chinoise majeure pour son dispositif Sonovein® et progresse vers l'accès au marché en Chine, renforçant ainsi sa position dans le secteur des technologies médicales avancées Marché Chinois Technologies Médicales Theraclion SONOVEIN® Certification Chinoise
BRIEF published on 10/10/2025 at 18:35, 5 months 12 days ago Monthly publication of Theraclion voting rights Share Capital Voting Rights Investment Euronext Growth Theraclion
BRIEF published on 10/10/2025 at 18:35, 5 months 12 days ago Publication mensuelle des droits de vote de Theraclion Investissement Droits De Vote Capital Social Euronext Growth Theraclion
PRESS RELEASE published on 10/10/2025 at 18:30, 5 months 12 days ago Inside Information / Other news releases Theraclion provides monthly update on total voting rights and shares. The French MedTech company uses focused ultrasound for non-invasive treatment. CE-marked platform SONOVEIN® targets varicose veins Voting Rights Shares Theraclion SONOVEIN Focused Ultrasound
PRESS RELEASE published on 10/10/2025 at 18:30, 5 months 12 days ago Informations privilégiées / Autres communiqués Communiqué mensuel sur les droits de vote et actions de Theraclion, société française de MedTech. Détails des actions en circulation et droits de vote réels Euronext PEA PME MedTech France Theraclion
BRIEF published on 09/15/2025 at 18:35, 6 months 7 days ago Theraclion Réussit son Étude Pivotal avec un Taux d'Occlusion de 96,8 % FDA Essai Clinique Theraclion SONOVEIN® Varices
BRIEF published on 09/15/2025 at 18:35, 6 months 7 days ago Theraclion Successfully Completes Pivotal Study with 96.8% Occlusion Rate FDA Clinical Trial Theraclion SONOVEIN® Varicose Veins
PRESS RELEASE published on 09/15/2025 at 18:30, 6 months 7 days ago Informations privilégiées / Autres communiqués Theraclion annonce le succès de son étude pivotale américaine FDA avec un taux d'occlusion de 96,8% pour Sonovein®, sa plateforme de traitement des varices par ultrasons focalisés de haute intensité FDA Theraclion SONOVEIN Étude Pivotale Occlusion
Published on 03/23/2026 at 14:05, 2 hours 34 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 2 hours 39 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 3 hours 34 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 4 hours 7 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 4 hours 9 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 15:05, 1 hour 34 minutes ago Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 1 hour 58 minutes ago CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 2 hours 9 minutes ago Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 2 hours 9 minutes ago Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 08:10, 8 hours 29 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 21 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 21 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 22 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 22 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
